Fred Hutch researchers engineer complex TCR immunotherapy that may target relapsing leukemia
Credit: Fred Hutch file photo SEATTLE - Oct. 25, 2017 - Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed...




